New Orleans, LA, United States of America

Conrad A Hornick



Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • New Orleans, LA (US) (2008 - 2011)
  • Makawao, HI (US) (2013)

Company Filing History:


Years Active: 2008-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Conrad A. Hornick: Pioneering Antiangiogenic Research**

Introduction

Conrad A. Hornick is an innovative inventor based in New Orleans, LA, who has made significant strides in the field of antiangiogenic research. His work primarily focuses on the therapeutic properties of Noni juice, leading to fruitful outcomes in the battle against cancer and other diseases associated with increased angiogenesis.

Latest Patents

Hornick holds three patents, with his most recent studies demonstrating the efficacy of Noni juice and its protein-free, alcohol precipitate in inhibiting angiogenesis in vitro. His research found that when growth medium contained Noni juice at concentrations ranging from about 2.5% to about 33% by volume, it effectively blocked angiogenesis. The juice and its ethanol precipitate not only inhibited the growth of new vessels but also targeted pre-existing angiogenic responses, featuring promising applications in treating various forms of cancer and non-cancerous diseases such as diabetic retinopathy and psoriasis. A carbohydrate with a molecular weight of less than about 6000 Daltons has been identified as the primary antiangiogenic component.

Career Highlights

Conrad A. Hornick is affiliated with Louisiana State University and Agricultural & Mechanical College, where he continues to push the boundaries of medical research. His contributions to understanding the role of Noni juice in angiogenesis have positioned him as a leading figure in his field. The implications of his research extend to treating conditions like retinopathy of prematurity and neovascular glaucoma, addressing critical healthcare challenges.

Collaborations

Throughout his career, Hornick has collaborated with notable individuals in the research community, including Eugene A. Woltering and Amy E. Myers. These partnerships have fostered an environment of innovation and progress, enhancing the impact of their combined research efforts.

Conclusion

Conrad A. Hornick's dedication to his research and his groundbreaking work with Noni juice underscores the importance of innovative approaches in the fight against cancer and other angiogenesis-related diseases. His patents stand as a testament to the potential of his findings, offering hope for future advancements in medical treatments. As the landscape of biomedical research continues to evolve, Hornick's contributions will undoubtedly remain pivotal in shaping new therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…